Kivu Bioscience
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Market Plaza Floor 17 of the Steuart T...Website
www.kivubioscience.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Kivu Bioscience
Kivu Bioscience is pioneering next-generation antibody-drug conjugates (ADCs) in oncology. The companys proprietary linker-payload technology delivers enhanced safety and efficacy, minimizing off-target effects to improve patient outcomes. With multiple ADC programs in development and a team of industry veterans, Kivu is advancing its first two lead candidates to clinical trials expected to begin in 2025. The company is headquartered in San Francisco, CA.Explore more
Popular SearchesKivu BioscienceSIC Code 28,283NAICS Code 32,325Show moreKivu Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kivu Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Kivu Bioscience launches new products
Earning: See what the market has to say on Kivu Bioscience recently announced quarterly report
Check if Kivu Bioscience has recently received funding, and reach out quickly before it becomes old news!
Click to see if Kivu Bioscience had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Kivu Bioscience has new funding data
Kivu Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Kivu Bioscience
Check out if Kivu Bioscience is spiking on competitors!
Recommended Actions
Find VP level buyers at Kivu Bioscience
Find 3 more new buyers
Company Profile Activity
Activity Insights
Kivu Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kivu Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kivu Bioscience.
Kivu Bioscience financials insights
Gather financial insights about Kivu Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$92M
Most Recent Scoops
Promotion
Executive Move
Executive Moves, Promotion
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Partnership
Partnership, Research & Development, Medical Research, Manufacturing Operations
Funding
Funding
Kivu Bioscience News & Media
Kivu Bioscience Appoints Mohit Trikha, Ph.D., as Chief Executive Officer - Eagle-Tribune
SAN MATEO, Calif.--(BUSINESS WIRE)--Apr 14, 2026--Kivu Bioscience Appoints Mohit Trikha, Ph.D., as Chief Executive Officer - Rutland Herald
SAN MATEO, Calif.--(BUSINESS WIRE)--Apr 14, 2026--Kivu Bioscience Selects Sterling Pharma Solutions for cGMP Manufacturing of Lead Oncology Antibody-Drug Conjugate KIVU-107
SAN FRANCISCO--(BUSINESS WIRE)-- #ADC--Kivu Bioscience Selects Sterling Pharma Solutions for cGMP Manufacturing of Lead Oncology Antibody-Drug Conjugate KIVU-107
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kivu Bioscience
Sign Up For FreeTo access detailed company insights
Kivu Bioscience is pioneering next-generation antibody-drug conjugates (ADCs) in oncology. The companys proprietary linker-payload technology delivers enhanced safety and efficacy, minimizing off-target effects to improve patient outcomes. With multiple ADC programs in development and a team of industry veterans, Kivu is advancing its first two lea... Read More
